HIGH-THROUGHPUT ORGANIC SYNTHESIS
	Cambridge Healthtech Institute , San Diego, California February 9-11, 2000
	The demand for novel leads, to be screened against a rapidly growing range of targets in ever faster high throughput screening, all work to increase demand for more rapid synthesis of compounds. At the same, quantity of compounds is not the measure of success, since value is produced from the discovery of unique compound series with acceptable drug-like properties. Devising appropriate strategies involve a variety of tradeoffs that need to be considered; from the range of chemistries to the range of scaffolds to the quantity and purity level of each compound produced. This conference provides an in-depth view of how these issues are being addressed, or new approaches under development, by giving you specific examples that can be applied to challenges that you face in optimizing compound synthesis.
	Organized by:	Cambridge Healthtech Institute
	Deadline for Abstracts:	January 7, 2000
	Registration:	Available on-line
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: 140.239.39.137 date: November 18, 1999 19:34:34 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.